Influenza and respiratory syncytial virus infections in the oldest-old continent.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 25 04 2020
accepted: 17 06 2020
pubmed: 1 7 2020
medline: 24 10 2020
entrez: 29 6 2020
Statut: ppublish

Résumé

SARS-CoV-2 dramatically revealed the sudden impact of respiratory viruses in our lives. Influenza and respiratory syncytial virus (RSV) infections are associated with high rates of morbidity, mortality, and an important burden on healthcare systems worldwide, especially in elderly patients. The aim of this study was to identify severity predictors in the oldest-old admitted with influenza and/or RSV infections. This is a multicenter, retrospective study of all oldest-old patients (≥ 85 years old) admitted for laboratory-confirmed influenza and/or RSV infection in three tertiary hospitals in Portugal, Italy, and Cyprus over two consecutive winter seasons. The outcomes included the following: pneumonia on infection presentation, use of non-invasive ventilation (NIV), and in-hospital death (IHD). The association with possible predictors, including clinical features and type of virus infection, was assessed using uni- and multivariable analyses. A total of 251 oldest-old patients were included in the study. Pneumonia was evident in 32.3% (n = 81). NIV was implemented in 8.8% (n = 22), and IHD occurred in 13.9% (n = 35). Multivariable analyses revealed that chronic obstructive pulmonary disease (COPD) or asthma was associated with pneumonia (OR 1.86; 95% CI 1.02-3.43; p = 0.045). COPD or asthma (OR 4.4; 95% CI 1.67-11.6; p = 0.003), RSV (OR 3.12; 95% CI 1.09-8.92; p = 0.023), and influenza B infections (OR 3.77; 95% CI 1.06-13.5; p = 0.041) were associated with NIV use, respectively, while chronic kidney disease was associated with IHD (OR 2.50; 95% CI 1.14-5.51; p = 0.023). Among the oldest-old, chronic organ failure, such as COPD or asthma, and CKD predicted pneumonia and IHD, respectively, beyond the importance of viral virulence itself. These findings could impact on public health policies, such as fostering influenza immunization campaigns, home-based care programs, and end-of-life care. Filling knowledge gaps is crucial to set priorities and advise on transition model of care that best fits the oldest-old.

Identifiants

pubmed: 32594325
doi: 10.1007/s10096-020-03959-9
pii: 10.1007/s10096-020-03959-9
pmc: PMC7320245
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2085-2090

Références

Med Mal Infect. 2018 Sep;48(6):377-382
pubmed: 29548714
J Infect Dis. 2012 Jul 1;206(1):56-62
pubmed: 22529314
Epidemiol Infect. 2019 Nov 28;147:e310
pubmed: 31775940
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Open Forum Infect Dis. 2019 Feb 15;6(3):ofz053
pubmed: 30895200
J Med Libr Assoc. 2020 Jan;108(1):59-66
pubmed: 31897052
Infection. 2019 Jun;47(3):425-433
pubmed: 30649684
Drugs Aging. 2015 Apr;32(4):261-9
pubmed: 25851217
Eur J Intern Med. 2020 Apr;74:86-91
pubmed: 31899057
BMC Infect Dis. 2017 Dec 20;17(1):785
pubmed: 29262784
CMAJ. 2009 Jan 20;180(2):175-82
pubmed: 19153394
Aging Clin Exp Res. 2017 Oct;29(5):833-845
pubmed: 27761759
Clin Interv Aging. 2013;8:1489-96
pubmed: 24235821
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Clin Infect Dis. 2013 Oct;57(8):1069-77
pubmed: 23876395
JAMA. 2020 May 19;323(19):1969-1971
pubmed: 32275293
Intensive Care Med. 2020 Feb;46(2):315-328
pubmed: 32040667
BMJ. 2019 Sep 10;366:l5021
pubmed: 31506273
Intern Med. 2016;55(7):731-7
pubmed: 27041156
Chest. 2016 Feb;149(2):526-534
pubmed: 26203671
Clin Infect Dis. 2019 Aug 30;69(6):1049-1052
pubmed: 30715225
Clin Microbiol Infect. 2019 Oct;25(10):1266-1276
pubmed: 30790685
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959
Yale J Biol Med. 2017 Jun 23;90(2):165-181
pubmed: 28656006

Auteurs

Matteo Boattini (M)

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy. matteo.boattini@unito.it.

André Almeida (A)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.
NOVA Medical School, Universidade Nova de Lisboa, Campo dos Mártires da Pátria 130, 1169-056, Lisbon, Portugal.

Eirini Christaki (E)

Medical School, University of Cyprus, Nicosia, Cyprus.
Department of Medicine, Nicosia General Hospital, Strovolos, Cyprus.

Lourenço Cruz (L)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.

Diogo Antão (D)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.

Maria Inês Moreira (MI)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.

Gabriele Bianco (G)

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.

Marco Iannaccone (M)

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.

Georgios Tsiolakkis (G)

Department of Medicine, Nicosia General Hospital, Strovolos, Cyprus.

Elina Khattab (E)

Medical School, University of Cyprus, Nicosia, Cyprus.

Diamanto Kasapi (D)

Medical School, University of Cyprus, Nicosia, Cyprus.

Lorena Charrier (L)

Department of Public Health and Paediatrics, University of Torino, Turin, Italy.

Valentina Tosatto (V)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.

Torcato Moreira Marques (TM)

Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Lisbon, Portugal.

Rossana Cavallo (R)

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.

Cristina Costa (C)

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH